ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1250

An Evaluation of Utilization Patterns and Appropriateness of Laboratory Tests Among New Referrals to Rheumatologists: Choosing Unwisely!

Sierra Barrett1, Azin Ahrari1, Sherry Rohekar2, Pari Basharat3 and Janet E. Pope4, 1Schulich School of Medicine and Dentistry, London, ON, Canada, 2Western University, London, ON, Canada, 3St. Joseph's Health Care London, London, ON, Canada, 4Department of Medicine, University of Western Ontario, London, ON, Canada

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: ANA and laboratory tests

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Measures and Measurement of Healthcare Quality Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Laboratory testing comprises the highest volume procedure in medicine and is therefore an important target for improving healthcare spending and efficiency. Unnecessary testing both increases healthcare costs and results in higher false positive rates with associated costly downstream testing and procedures. Additionally, unnecessary testing increases the patient burden and may increase the probability of an adverse health event.

This study aimed to examine the utilization patterns, appropriateness, and associated cost of rheumatologic tests ordered for patients referred to a university rheumatology clinic. A secondary aim of this study was to determine whether demographic factors such as patient sex, reason for referral, and referring practice population size were predictive of inappropriate testing.

Methods:

This study consisted of a chart audit of consecutive referrals to three rheumatologists at an academic university rheumatology clinic over one year. All new referrals that had proper documentation, were not transfers of care, and did not have previously established diagnoses were considered. Of referrals that met inclusion criteria (n=631), 398 accepted and 233 rejected referrals were reviewed. Ordering of specific tests (ANA, ENA, anti-dsDNA, RF, and complement levels) and their appropriateness based on clinical presentation were extracted from medical charts. Lab tests ordered within 2 years prior to referral were collected for accepted referrals. Additionally, the reason for referral, diagnosis (accepted referrals), reason for rejection (rejected referrals), patient age and sex, and the population size of the referring practice was collected to identify potential predictors of inappropriate testing.

Results:

The number one reason for referral in accepted referrals and rejected referrals was seronegative spondyloarthropathy and fibromyalgia respectively. Of the referrals reviewed (n=631), 41% had at least one instance of inappropriate testing. ANA was most frequently ordered inappropriately, with 20% of all referrals having ANA testing with no clinical indication. Additionally, 56% of ANA testing in accepted referrals was repeated testing. Family physicians and nurse practitioners were significantly more likely to order inappropriate tests than specialists (p = 0.007). Chi-squared testing found patient age (p=0.445), gender (p=0.051), and population size (p=0.855) were not predictive of inappropriate testing.

Description: https://lh5.googleusercontent.com/mlo2rlYz-j9dRT1NSpnaIzgDIMVk_a5LMLAo1WOjGwdKAPl5vmTRRGWodIXDX-u4IgUgaUwYoJ0ADfwDVZy8QZEp_fUfbS54idUOchy2MoLi-T_8ve6TZM5JQ1dKlUBEvkJpOiPi

Conclusion:

The results of this study showed a significant problem with inappropriate testing in referrals made to this institution. Cost estimation of inappropriate testing identified a potential cost reduction of 49%. Future research should focus both on implementing existing guidelines, and on creating interventions tailored to family medicine practice to produce the greatest reduction in cost.


Disclosure: S. Barrett, None; A. Ahrari, None; S. Rohekar, Abbvie, Amgen, Eli-Lily, Janssen, Merck, Novartis, Pfizer, Roche, UCB, 5,Eli-Lily, 8; P. Basharat, None; J. E. Pope, AbbVie Inc., 5,Amgen Inc., 5,Bristol-Myers Squibb, 5,Lilly, 5,Merck & Co., 5,Novartis, 5,Pfizer, Inc., 5,Roche, 5,Sanofi, 5,Sandoz, 5,Celltrion, 5,United Chemicals Belgium, 2.

To cite this abstract in AMA style:

Barrett S, Ahrari A, Rohekar S, Basharat P, Pope JE. An Evaluation of Utilization Patterns and Appropriateness of Laboratory Tests Among New Referrals to Rheumatologists: Choosing Unwisely! [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/an-evaluation-of-utilization-patterns-and-appropriateness-of-laboratory-tests-among-new-referrals-to-rheumatologists-choosing-unwisely/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/an-evaluation-of-utilization-patterns-and-appropriateness-of-laboratory-tests-among-new-referrals-to-rheumatologists-choosing-unwisely/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology